Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies
Publication
, Journal Article
Scherer, MN; Graeb, C; Knechtle, SJ; Jauch, KW; Geissler, EK
Published in: LANGENBECKS ARCHIVES OF SURGERY
January 1, 1999
Duke Scholars
Published In
LANGENBECKS ARCHIVES OF SURGERY
ISSN
1435-2443
Publication Date
January 1, 1999
Start / End Page
423 / 426
Publisher
SPRINGER VERLAG
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Scherer, M. N., Graeb, C., Knechtle, S. J., Jauch, K. W., & Geissler, E. K. (1999). Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies. LANGENBECKS ARCHIVES OF SURGERY, 423–426.
Scherer, M. N., C. Graeb, S. J. Knechtle, K. W. Jauch, and E. K. Geissler. “Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies.” LANGENBECKS ARCHIVES OF SURGERY, January 1, 1999, 423–26.
Scherer MN, Graeb C, Knechtle SJ, Jauch KW, Geissler EK. Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies. LANGENBECKS ARCHIVES OF SURGERY. 1999 Jan 1;423–6.
Scherer, M. N., et al. “Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies.” LANGENBECKS ARCHIVES OF SURGERY, SPRINGER VERLAG, Jan. 1999, pp. 423–26.
Scherer MN, Graeb C, Knechtle SJ, Jauch KW, Geissler EK. Use of a soluble RT1A(a)/IgG chimeric molecule to prevent the cytotoxic effects of preformed anti-donor antibodies. LANGENBECKS ARCHIVES OF SURGERY. SPRINGER VERLAG; 1999 Jan 1;423–426.
Published In
LANGENBECKS ARCHIVES OF SURGERY
ISSN
1435-2443
Publication Date
January 1, 1999
Start / End Page
423 / 426
Publisher
SPRINGER VERLAG
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences